Skip to main content

Table 2 Comparison of therapeutic response evaluation between CT and PET criteria

From: Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer

Variables

RECIST 1.0

irRECIST

Responder

Non-responder

Total

(κ)

Responder

Non-responder

Total

(κ)

PERCIST

SULpeak

  Responder

4

15

19

(κ = 0.22)

4

15

19

(κ = 0.22)

  Non-responder

1

34

35

1

34

35

  Total

5

49

54

5

49

54

MTV

  Responder

3

9

12

(κ = 0.25)

3

9

12

(κ = 0.18)

  Non-responder

2

40

42

2

40

42

  Total

5

40

54

5

49

54

TLG

  Responder

3

12

15

(κ = 0.18)

3

12

15

(κ = 0.18)

  Non-responder

2

37

39

2

37

39

  Total

5

49

54

5

49

54

iPERCIST

SULpeak

  Responder

4

12

16

(κ = 0.28)

4

11

15

(κ = 0.30)

  Non-responder

1

37

38

1

38

39

  Total

5

49

54

5

49

54

MTV

  Responder

4

10

14

(κ = 0.33)

3

9

12

(κ = 0.25)

  Non-responder

1

39

40

2

40

42

  Total

5

49

54

5

49

54

TLG

  Responder

3

12

15

(κ = 0.28)

3

12

15

(κ = 0.18)

  Non-responder

2

37

39

2

37

39

  Total

5

49

54

5

49

54

EORTC criteria

SULpeak

  Responder

3

17

20

(κ = 0.10)

3

17

20

(κ = 0.11)

  Non-responder

2

32

34

2

32

34

  Total

5

49

54

5

49

54

MTV

  Responder

4

11

15

(κ = 0.30)

3

11

14

(κ = 0.21)

  Non-responder

1

38

39

2

38

40

  Total

5

49

54

5

49

54

TLG

  Responder

3

14

17

(κ = 0.15)

3

14

17

(κ = 0.15)

  Non-responder

2

35

37

2

35

37

  Total

5

49

54

5

49

54

  1. Abbreviations: CT Computed tomography, PET Positron emission tomography, RECIST Response Evaluation Criteria Solid in Tumors, irRECIST Immune modified Response Evaluation Criteria Solid in Tumors, PERCIST PET Evaluation Criteria in Solid Tumors, iPERCIST Immune modified Response Evaluation Criteria Solid in Tumors, EORTC European Organization for Research and Treatment of Cancer, SULpeak The peak standardized uptake value normalized by lean body mass, MTV Metabolic tumor volume, TLG Total lesion glycolysis, (κ) The value of agreement between two assessments using Cohen κ coefficient